[1] 胡美娜,朱莉,曾亚悦,等.个体化卵巢癌新抗原的预测和免疫原性验证[J].现代医学,2022,50(8):995-1002.
[2] ANGLESIO M S,YONG P J.Endometriosis-associated ovarian cancers[J].Clin Obstet Gynecol,2017,60(4):711-727.
[3] KRALICKOVA M,LAGANA A S,GHEZZI F,et al.Endometriosis and risk of ovarian cancer:what do we know?[J].Arch Gynecol Obstet,2020,301(1):1-10.
[4] 郎景和.子宫内膜异位症和肿瘤兼论子宫内膜异位症恶变[J].中华妇产科杂志,2019,54(9):577-581.
[5] HERMENS M,VAN ALTENA A M,NIEBOER T E,et al.Incidence of endometrioid and clear-cell ovarian cancer in histological proven endometriosis:the ENOCA population-based cohort study[J].Am J Obstet Gynecol,2020,223(1):101-107.
[6] XUE Z,WU X,CHEN X,et al.Mesenchymal stem cells promote epithelial to mesenchymal transition and metastasis in gastric cancer though paracrine cues and close physical contact[J].J Cell Biochem,2015,116(4):618-627.
[7] KWON Y J,SHIN S,CHUN Y J.Biological roles of cytochrome P450 1A1,1A2,and 1B1 enzymes[J].Arch Pharm Res,2021,44(1):63-83.
[8] MCCALLION A,NASIRZADEH Y,LINGEGOWDA H,et al.Estrogen mediates inflammatory role of mast cells in endometriosis pathophysiology[J].Front Immunol,2022,13:1-15.
[9] YU K,HUANG Z Y,XU X L,et al.Estrogen receptor function:impact on the human endometrium[J].Front Endocrinol(Lausanne),2022,13:724-740.
[10] MENON U,KARPINSKYJ C,GENTRY-MAHARAJ A.Ovarian cancer prevention and screening[J].Obstet Gynecol,2018,131(5):909-927.
[11] ABRAMIUK M,GRYWALSKA E,MALKOWSKA P,et al.The role of the immune system in the development of endometriosis[J].Cells,2022,11(13):2028-2051.
[12] CHANG C M,WANG M L,LU K H,et al.Integrating the dysregulated inflammasome-based molecular functionome in the malignant transformation of endometriosis-associated ovarian carcinoma[J].Oncotarget,2018,9(3):3704-3726.
[13] LEENEN S,HERMENS M,DE VOS V S P,et al.Immunologic factors involved in the malignant transformation of endometriosis to endometriosis-associated ovarian carcinoma[J].Cancer Immunol Immunother,2021,70(7):1821-1829.
[14] LI Y,ZENG X,LU D,et al.Erastin induces ferroptosis via ferroportin-mediated iron accumulation in endometriosis[J].Hum Reprod,2021,36(4):951-964.
[15] LI B,DUAN H,WANG S,et al.Ferroptosis resistance mechanisms in endometriosis for diagnostic model establishment[J].Reprod Biomed Online,2021,43(1):127-138.
[16] KAJIYAMA H,SUZUKI S,YOSHIHARA M,et al.Endometriosis and cancer[J].Free Radic Biol Med,2019,133:186-192.
[17] 侯婉云,刘发煇,龙朴泽,等.肿瘤微环境对铁死亡的影响[J].实用肿瘤杂志,2022,37(4):371-375.
[18] ATIYA H I,FRISBIE L,GOLDFELD E,et al.Endometriosis-associated mesenchymal stem cells support ovarian clear cell carcinoma through iron regulation[J].Cancer Res,2022,82(24):4680-4693.
[19] HOSSAIN M M,NAKAYAMA K,SHANTA K,et al.Establishment of a novel in vitro model of endometriosis with oncogenic KRAS and PIK3CA mutations for understanding the underlying biology and molecular pathogenesis[J].Cancers(Basel),2021,13(13):3174-3193.
[20] KHALIQUE S,LORD C J,BANERJEE S,et al.Translational genomics of ovarian clear cell carcinoma[J].Semin Cancer Biol,2020,61:121-131.
[21] VERAS E,MAO T L,AYHAN A,et al.Cystic and adenofibromatous clear cell carcinomas of the ovary:distinctive tumors that differ in their pathogenesis and behavior:a clinicopathologic analysis of 122 cases[J].Am J Surg Pathol,2009,33(6):844-853.
[22] SHEN J,PENG Y,WEI L,et al.ARID1A deficiency impairs the DNA damage checkpoint and sensitizes cells to PARP inhibitors[J].Cancer Discov,2015,5(7):752-767.
[23] DINULESCU D M,INCE T A,QUADE B J,et al.Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer[J].Nat Med,2005,11(1):63-70.
[24] MADSEN R R,VANHAESEBROECK B,SEMPLE R K.Cancer-associated PIK3CA mutations in overgrowth disorders[J].Trends Mol Med,2018,24(10):856-870.
[25] SUN Y,LIU G.Endometriosis-associated ovarian clear cell carcinoma:a special entity?[J].J Cancer,2021,12(22):6773-6786.
[26] VARGA J,REVICZKA A,HAKOVA H,et al.Predictive factors of endometriosis progression into ovarian cancer[J].J Ovarian Res,2022,15(1):5-18.
[27] TOMOHIRO M,MATSUMOTO T,MIURA R,et al.Alterations in beta-catenin,microsatellite instability,and HNF-1beta levels are independently associated with ovarian endometriosis-associated tumorigenesis[J].Hum Pathol,2019,89:10-23.
[28] THROWBA H P,UNNIKRISHNAN L,PANGATH M,et al.The epigenetic correlation among ovarian cancer,endometriosis and PCOS:a review[J].Crit Rev Oncol Hematol,2022,180:852-870.
[29] XIA Y,XIONG N,HUANG Y.Relationship between methylation status of RASSF2A gene promoter and endometriosis-associated ovarian cancer[J].J Biol Regul Homeost Agents,2018,32(1):21-28.
[30] 张洁,张吉瑞,张蕾.miRNA-133b和miRNA-150对非小细胞肺癌的诊断价值[J].肿瘤研究与临床,2021,33(7):508-512.
[31] BRAICU O L,BUDISAN L,BUIGA R,et al.miRNA expression profiling in formalin-fixed paraffin-embedded endometriosis and ovarian cancer samples[J].Onco Targets Ther,2017,10:4225-4238.
[32] WANG D,LUO Y,WANG G,et al.CircATRNL1 promotes epithelial-mesenchymal transition in endometriosis by upregulating Yes-associated protein 1 in vitro[J].Cell Death Dis,2020,11(7):594-607.
[33] TRANOULIS A,BURUIANA F H,GUPTA B,et al.Friend or foe? The prognostic role of endometriosis in women with clear cell ovarian carcinoma.A UK population-based cohort study[J].Arch Gynecol Obstet,2022,305(5):1279-1289.
[34] 杨珈苹.子宫内膜异位症相关性卵巢癌的研究进展[J].中国计划生育和妇产科,2022,14(5):58-62.
[35] ZHOU L,YAO L,DAI L,et al.Ovarian endometrioid carcinoma and clear cell carcinoma:a 21-year retrospective study[J].J Ovarian Res,2021,14(1):63-75.
[36] 中华医学会超声医学分会妇产超声学组.子宫内膜异位症超声评估中国专家共识[J].中华超声影像学杂志,2022,31(10):837-844.
[37] KAWAHARA N,MIYAKE R,YAMANAKA S,et al.A novel predictive tool for discriminating endometriosis associated ovarian cancer from ovarian endometrioma:the R2 predictive index[J].Cancers(Basel),2021,13(15):3829-3839. |
